Interaction of sulphinpyrazone with warfarin
β Scribed by J. O. Miners; T. Foenander; S. Wanwimolruk; A. S. Gallus; D. J. Birkett
- Publisher
- Springer
- Year
- 1982
- Tongue
- English
- Weight
- 470 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Warfarin is the most common agent used for control and prevention of venous as well as arterial thromboembolism (blood clots). In aqueous media, warfarin forms inclusion complexes with a family of cyclic oligosaccharides, Ξ±, Ξ², Ξ³βcyclodextrins (CD). The formation of these complexes resu
The influence of tenoxicam on plasma warfarin concentrations and on its anticoagulant effect has been studied in healthy volunteers. Tenoxicam did not alter the plasma warfarin concentration versus time profile. Treatment with it for 14 days had no effect on the average dose of warfarin required to